AU712507B2 - Chiral ruthenium (II) BINAP and t-BINAP compounds - Google Patents

Chiral ruthenium (II) BINAP and t-BINAP compounds Download PDF

Info

Publication number
AU712507B2
AU712507B2 AU89399/98A AU8939998A AU712507B2 AU 712507 B2 AU712507 B2 AU 712507B2 AU 89399/98 A AU89399/98 A AU 89399/98A AU 8939998 A AU8939998 A AU 8939998A AU 712507 B2 AU712507 B2 AU 712507B2
Authority
AU
Australia
Prior art keywords
binap
nitrogen
nmr
mixture
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU89399/98A
Other versions
AU8939998A (en
Inventor
Joseph D. Armstrong Iii
Lisa Dimichele
Alan W. Douglas
Jennifer L. Keller
Steven A. King
Andrew S. Thompson
Thomas R. Verhoeven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/177,481 external-priority patent/US5508435A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to AU89399/98A priority Critical patent/AU712507B2/en
Publication of AU8939998A publication Critical patent/AU8939998A/en
Application granted granted Critical
Publication of AU712507B2 publication Critical patent/AU712507B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Description

S F Ref: 341281D1
AUSTRALIA
PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT
ORIGINAL
*c U U
U.
Name and Address of Applicant: Actual Inventor(s): Merck Co., Inc.
126 East Lincoln Avenue Rahway New Jersey 07065 UNITED STATES OF AMERICA Joseph D. Armstrong III, Lisa DiMichele, Alan W.
Douglas, Jennifer L. Keller, Steven A. King, Andrew S.
Thompson and Thomas R. Verhoeven Spruson Ferguson, Patent Attorneys Level 33 St Martins Tower, 31 Market Street Sydney, New South Wales, 2000, Australia fnQ P r r 0 I^ nr( Address for Service: Invention Title: j J L'JI 'I jJ 'I j 'd JW 3W V c II er y- Kcteamides- Ckr~ ~t Aeni0em' k.AP C l) B CrNR* The following statement is a full description of this invention, including the best method of performing it known to me/us:- 5845 Chiral Ruthenium (II) BINAP and t-BINAP Compo-inds Summary of the Invention The present invention relates to chiral ruthenium (II) BINAP and t-BINAP compounds.
Brief Description of the Figures Figure 1: 250 MHz 1 H NMR of [(C2H)2NH 2
]+[RU
2 CI5((R)-BINAP) 2 -*oCH 3 Ph in CD 2 2 at room temperature.
Figure 2: Expansion of the 3.0 ppm to 3.5 ppm region of 400.13 MHz 1 H NMR of [(C2HS) 2
NH
2 +[RU2CI5((R)-BINAP)2-0CH 3 Ph in CD 2
CI
2 at -40 0 C. is the fully coupled spectrum of this region; (b) is the decoupled spectrum of this region resulting from the irradiation of the peak at 8.53 ppm; and (c) is the decoupled spectrum of this region resulting from the irradiation of the peak at 1.41 ppm.
Detailed Description of the Invention The compounds of the present invention are as follows: A compound of structural formula: Cl np/I ~C I l Cl .pp, 15is or solvates thereof wherein P Prepresents BINAP or t-BINAP.
A compound of structural formula: r H 2 Cl Cl Ru-s >Ru CI H 2 or solvates thereof wherein P P represents BINAP or t-BINAP.
A compound of structural formula: 0
U
U.
OU
U
U U U U U 0
U
e [Et 2
NH
2 or solvates thereof wherein P P represents BINAP or t-BINAP.
Abbreviations BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl t-BINAP 2,2'-bis(di-p-tolylphosphino)-1,1 '-binaphthyl BINAP in the present application represents all chiral ligands of 2,2'-bis (diarylphosphino)-1,1'binaphthyl and it is understood that although the specific stereochemistry is not recited that the ligand utilised is either the R- or the S-antipode. The selection of the R- or the S- [R:\LIBAAj07612.doc:TAB 2 BINAP ligand will determine the stereochemistry of the P- or y-hydroxyesters and p- or yhydroxyamides produced.
*The asterisk is being used to represent a specific enantiomer which is dependent on the stereochemistry of the BINAP employed.
1 N/mm 2 is equivalent to approximately 0.145 psi Boc t-butyloxycarbonyloxy Ms methanesulfonyl COD Cyclooctadienyl om overlapping multiplet The following examples further illustrate the use of the process for the preparation of the compounds of Formula I and the use of this catalyst in this process and, as such, are not to be considered or construed as limiting the invention recited in the appended claims.
Example 1 Catalyst Preparation e Ph2P (PhCH3)2P Ph 2 P (PhCH 3 2
P
P P represents (BINAP) or (t-
BINAP)
Step A: Preparation of [(C2H5)2NH2]+[Ru 2 CI5((R)-BINAP) 2
]-.CH
3 Ph Structure 12 (Cyclooctadienyl)ruthenium dichloride (214 mg, 0.76 mmol) and (R)-BINAP (500mg, 0.80mmol) were placed in a 50ml round bottom flask and connected to a double ended filter (Kontes #215500-6044) with a 100ml round bottom flask at the opposite end.
Aa07612 EDITORIAL NOTE NUMBER 89399/98 THIS SPECIFICATION DOES NOT CONTAIN PAGES 3 TO 11 Vacuum grease was used to ensure an air-tight seal. Rubber bands were a simple and effective way of holding the apparatus together. The entire apparatus was evacuated and filled with nitrogen. Dry toluene (17 mL) and dry triethylamine (1.7 mL), which had been deoxygenated with flowing nitrogen for several minutes, were added via the lower side arm. The vessel was sealed and the mixture heated to 140°C producing a deep brick red colored solution. After 4 hours the apparatus was allowed to cool to room temperature with vigorous stirring while the catalyst precipitated. The apparatus was vented to nitrogen and inverted to filter the product using vacuum on the lower side arm and nitrogen on the upper. The precipitate was washed with deoxygenated toluene (17 mL), and the flask containing the filtrate was exchanged for an empty one. (31P NMR showed that the filtrate contained none of the desired product.) The entire apparatus was put 15 under vacuum and the product was dried overnight to give 470 mg of a dark red solid: 1 H NMR (CD2Cl2, 400.13 MHz) D 8.53(br s, 2H), 8.07 J=8.8 Hz, 4H), 7.82 J=8.3 Hz, 2H), 7.65 6H), 7.55 4H), 7.47 4H), 7.4-7.1 18H), 6.95 2H), 6.84 J=7.4 Hz, 2H), 6.8-6.7 (om, 20 4H), 6.7-6.6 (om, 4H), 6.6-6.5 (om, 12H), 3.24 (br m, 6H), 2.3 (s,3H), 1.45 J=7.3 Hz, 9H) [See figure 1 for 1 H NMR spectrum]; 3 1 p NMR (CD2C12, 161.98 MHz) a 56.5 J=38.0 Hz), 52.3 J=38.0 Hz); Analysis Calc'd for C99H84Cl5NP4Ru2: C 66.39, H 4.73, N 0.78, Cl 9.90, P 6.92; Found C 66.06, H 4.74, N 0.74, Cl 9.79, P 6.91.
Decoupling and spiking experiments unequivocally established the presence of diethylammonium ion. At -40°C the methylene protons of the diethylammonium appear as two multiplets at 3.2 ppm. [See figure 2 for 1H NMR spectrum] When the triplet at 1.4 ppm was irradiated the signal at 3.2 ppm appears as two doublets of triplets. [See figure 2 for 1 H NMR spectrum] When the broad singlet at 8.53 ppm is irradiated the signal at 3.2 ppm appears as two doublets of quartets. [See figure 2 for 1H NMR spectrum]. When 12diethylamine was added to the solution the signal at 3.2 ppm was seen to coalesce with the diethylamine signal. Triethylamine did not produce this behavior.
CIl C /q 'Ci-HUp
CI
13 Ph 2 P or(PhCH) 2
P
*P P represents P or PhCH Ph 2 P (PhCH3)2 Step B: Preparation of RuC14((R)-BINAP)2 Structure 13 20 The catalyst 12 (12 mg, 6.7 gmol) was loaded into a gas tight NMR tube (available from Wilmad) which was evacuated and refilled with nitrogen. Dry methylene chloride-d2 (0.8 mL) was deoxygenated by bubbling with nitrogen for 2 minutes. It was added with a thin needle by partially unstoppering the tube while nitrogen was flowing through the plug, flushing air away from its mouth. The atmosphere over the solvent was immediately purged by carefully evacuating and refilling with nitrogen. Catalyst dissolution was aided by the use of sonication or a vortex mixer. Methanesulfonic acid (4 gL, 62 gmol) was added to give the desired product: 1 H NMR (CD2Cl2, 400.13 MHz) a 8.14 J=7.9 Hz, 2H), 8.10 (d,d, J=9.1,1.6 Hz, 2H), 7.73 J=7.9 Hz, 2H), 7.65 J=7.5 Hz, 2H), 7.59 2H), 7.55-7.35 (om, 22H), 7.26-7.09 (om, 18H), 6.82-6.77 (om, 4H), 6.15 4H), 6.05 J=8.7 Hz, 2H), 5.83 (dd, J=12.3, 7.9 Hz, 13 4H); 3 1P NMR (CD2CI2, 161.98 MHz) D 62.6 J=40.3 Hz), 13.7 (d, J=40.3 Hz).
S
H
2 C 1
P
RU
H
2 14 PhP(PhCH)P P P represents Ph2' or P C 32 so. Step C: Preparation of rRuC14R BNAP)( H94-rel so. 0 A gas tight NMR tube containing 13 was put under a hydrogen atmosphere by evacuating and filling with hydrogen at a positive pressure of 8 psi. To ensure saturation of the solution, the tube a was put on a vortex mixer while attached to the manifold and stirred for 10 minutes.
so The I 1 H and 3 1 p spectra indicate that the hydrogen adduct is a mixture of conformational or configurational forms.
I H NMR (CD2Cl2, 400.13 MHz) D 8.2-5.8 -9.85, -10.08, -10.2, -10.88, -11.12, -11.52; 3 1 p NMR (CD2CI2, 161.98 MHz) D 58.8 (d, J=29.7 Hz), 56.2 J=30.4 Hz), 55.1 J=32.4 Hz), 54.9 J=31.7 Hz), 51.7 J=29.7 Hz), 50.9 J=31.0 Hz), 50.5 J=33.1 Hz), 48.5 J=31.7 Hz), 47.2 J=30.4 Hz), 46.7 J=33.1 Hz), 46.4 (d, J=32.4 Hz), 44.9 J=3 1.0 Hz).
The species 13 and 14 have been shown to be active catalysts as demonstrated in the following experiment: 14- To the above mixture methyl acetoacetate (20 pL) and methanol (100 gL) were added, and the NMR signals for species 14 immediately disappeared and methyl 4 -hydroxybutyrate and 13 appeared. After standing over night, the hdroxy product was isolated.
Examination of the (S)-Mosher ester of methyl 4 -hydroxybutyrate showed the product to be >90 enantiomeric excess.
EXAMPLE 2 10 _25_2_2NlRuC15 ((R)-t-BINAP ]toluene *0 I ^P(PhCH)2
H
3 2 1.4 hr, 1400C, Ph u C RuCl 2 (COD)n- -P(PhCH3)2 2. filter S2P(PhCH 3 3. Crystallize from heptanes *i PhCH PhCH [Et 2
NH
2 PhCH3 P, Cl P CI-Ru-CI-Ru-CI p Cl p
N:_
I PhCH 3
/I
PhCH CH3Ph fi CPhCH 3 To a 50 mL round bottom flask was charged 500 mg of (S)-t-BINAP 1, 197 mg of RuCl2[COD]n polymer 2, 1.4 mL of Et3N and 17 mL of degassed toluene. The flask was sealed and heated to 140 0 C for 6 hours. The dark red homogeneous solution was cooled to ambient temperature and the solution was concentrated under reduced pressure to 8 mL. Then 12 mL of heptanes was added and the solution was stirred for one hour. The Ruthenium polymer precipitated and was filtered off via double ended filter. The homogeneous solution was concentrated under reduced pressure to 8 mL. Then 12 mL of heptanes was added and the solution was stirred for one hour. The catalyst precipated and was filtered off via doubled ended funnel (schlenk ware).
The precitate was dried under vacuum, giving 300 mg of light yellow solid for 55% yield.
EXAMPLE 3 (C2H5 2jNH21+RuC 1 5((R)-BINAP)21:xyvlene (Cyclooctadienyl)ruthenium dichloride (2.14 g, 7.6 mmol) and (R)-BINAP (5.00 g, 8.0 mmol) were placed in a 50 mL round bottom flask and connected to a double ended filter (Kontes #215500- 15 6044) with a 1000 mL round bottom flask at the opposite end. Vacuum grease was used to ensure an air-tight seal. The entire apparatus was evacuated and filled with nitrogen. Dry xylenes (170 mL) and dry triethylamine (17 mL), which had been deoxygenated with flowing nitrogen for several minutes, were added via the lower side arm. The mixture was heated to 140 0 C producing a deep brick red colored solution. After 4 hours the apparatus was allowed to cool to room temperature with vigorous stirring while the catalyst precipitated. The apparatus inverted to filter the product using vacuum on the lower side arm and nitrogen on the upper. The precipitate was washed with deoxygenated xylene (17 mL), and the flask containing the filtrate was exchanged for an empty one. The entire apparatus was put under vacuum and the product was dried overnight to give 440 mg of a dark red solid: 1H NMR (CD2C12, 400.13 MHz) a 8.07 J=8.8 Hz, 4H), 7.82 J=8.3 Hz, 2H), 7.65 J=8.3 Hz, 6H), 7.55 4H), 7.47 4H), 7.4-7.1 (om, 20H), 6.95 2H), 6.84 J=7.4 Hz, 2H), 6.8- 6.7 (om, 4H), 6.7-6.6 (om, 4H), 6.6-6.5 (om, 12H), 3.24 6H), 2.3 (3 singlets, 6H), 1.45 J=7.3 Hz, 9H); 3 1 p NMR (CD2C12, 161.98 MHz) D 56.5 J=38.0 Hz), 52.3 J=38.0 Hz).
-16- EXAMPLE 4 t-Butvl 3 -hvdroxv-6-methoxv hexanoate O 0 0 0O 0 OH 10x^ 00 o 2 3 Step A: Preparation of t-butyl 3-keto-6-methoxy hexanoate 10 (Ketoester 2) The dianion of methyl acetoacetate, generated with sodium hydride and n-butyl lithium in THF at -15 0 C, is alkylated with 1.2 equivalents of bromoethyl methyl ether. The reaction proceeds in 6-8 hours to a level of 3 wt% residual starting material and is worked up with methyl t-butyl ether (MTBE) and saturated ammonium chloride solution. Residual methyl acetoacetate 159 0 C) is removed by flushing crude product with four to seven volumes of xylene to provide the alkylated ketoester containing <0.25 wt% methyl acetoacetate in 73- 77% yield.
20 The methyl ester is transesterified to the t-butyl ester in 95 :5-toluene:t-butanol by refluxing the solvent through 5A molecular sieves. The boiling point of the solvent mixture is 107-111 C, well above the boiling point of t-butanol, which can be slowly lost from the vessel and must be replaced as needed. After concentration, the t-butyl ester is produced in 95% yield with remaining methyl ester.
Step B: Preparation of t-butyl 3 -hydroxy-6-methoxy hexanoate (3hydroxvester 3) The hydrogenation catalyst [(C2H5)2NH2]+[Ru2Cl5((R)-
BINAP)
2 is not commercially available and must be prepared from [RuCl2(COD)]n and (R)-BINAP (see Example Twenty gram batches are conveniently prepared in a 1L flask. Use of a double ended filter allows convenient isolation of the product on this scale. The catalyst, which can be handled and weighed in air, should be stored under nitrogen.
i ri_ i~ __C -17- Asymmetric reduction of ketoester 2 is conducted in methanol at 45C under 1034 N/mm 2 (150 psi) hydrogen with 0.09 mol% (0.4 wt%) [(C2H5)2NH2]+[Ru2Cl5((R)-BINAP) 2 The reaction mixture should be deoxygenated with nitrogen and the vessel thoroughly evacuated and flushed with nitrogen prior to pressurization with hydrogen. The reaction is exothermic and requires periodic cooling to maintain the temperature at 450. After 4 hours hydrogen uptake is complete and the catalyst is precipitated with hexane and filtered away.
Concentration provides a >97% yield of the alcohol whose enantiomeric excess is determined to be 97% by proton NMR analysis of the derived Mosher ester.
The hydrogenation reaction is very susceptible to the presence of basic impurities and acidification of these with small amounts of strong acid is required.
Transesterification during the reaction can result from either high temperatures or the presence of excess amounts of acid.
Thus, the reaction temperature should be kept at 450 and the minimum S* possible amount of HCI should be used.
20 EXAMPLE tert-Butvl 3(R)-hvdroxvbutvrate 0 OH O CH3 OO- 0CH 3 16 tert-Butyl acetoacetate [15] (14.5 g, 90 mmol) and methanol mL) were mixed and deoxygenated with flowing nitrogen for minutes in a septum covered Parr shaker bottle. The catalyst prepared as described above (36 mg, 0.02 mmol) was added along with 2N HCI (0.041 mL, 0.082 mmol). The mixture was transferred to a standard Parr shaker apparatus and flushed by evacuating and refilling with nitrogen and then hydrogen several times. The apparatus was heated at with shaking under 50 psi of hydrogen. After 20 min the reaction -18became a homogeneous clear yellow solution which took up hydrogen for approximately eight hours. At this time the reaction was complete and the mixture was cooled and diluted with hexane (30 mL) to precipitate the catalyst, which was filtered away. The filtrate was concentrated to give tert-butyl 3 (R)-hydroxybutyrate [16] (14.5 g, 97%).
EXAMPLE 6 10 tert-Butyl 3 (R)-hvdroxvbutvrate Following the procedure described in Example 3 with the exception that 2N H2S04 was substituted for the 2N HCI tert-butyl acetoacetate was reduced to the titled product.
EXAMPLE 7 r
OH
H
H
NHCH
3 Boc O
O
17 MW 272.31 0.75% HCI, MeOH 0.25% [Et 2
NH
2 ]+[Ru 2 C 5
((S)-BINAP)
2 40 psi H 2 22h, 60 0
C
OH
NHCH 3 Boc OH 0 18 MW 274.31 In a 25 mL round bottom flask with a septum the P-keto amide 1 (1 g) was dissolved in methanol (4 mL). The solution was deoxygenated with nitrogen for 20 minutes and then the finely ground [(C2H5)2NH2]+[Ru2Cl5((S)-BINAP)2]- catalyst (15.5 mg) (prepared as described in Example 1) was added. The solution was degassed with nitrogen for 5 minutes and 2N hydrochloric acid (0.092 mL) was -19added. The mixture was cannulated into the reaction pressure vessel.
The apparatus was heated at 60 0 C with shaking under 40 psi of hydrogen for 20 hours.
After 20 h the reaction mixture was removed from the reaction pressure vessel. The vessel was rinsed with methanol (3 mL) which was combined with the reaction mixture. The solution was concentrated under reduced pressure to an off-white solid.
The crude reaction mixture gave a 87:13 ratio of the R:S hydroxy esters.
The yield was 100%.
EXAMPLE 8
HO
H 0.75% HCI, MeOH H NHCH3 N
NHC
3 0.25% [Et 2
NH
2 ]+[Ru 2
CI
5
((S)-BINAP)
2 HCI O O 40 psi H 2 22h, 600C
HHCI
MW 208.65
H
20 1 N HC H3
N
H OH 0
*HCI
MW 210.65 In a 25 mL round bottom flask with a septum the P-keto amide HCL salt 19 (1 g) was dissolved in methanol (16 mL). The solution was deoxygenated with nitrogen for 20 minutes and then the finely ground [(C2H5)2NH2]+[Ru2C15((S)-BINAP) 2 catalyst (20.2 mg) (prepared as described in Example 1) was added. The solution was degassed with nitrogen for 5 minutes and 2N hydrochloric acid (0.120 mL) was added. The mixture was cannulated into the reaction pressure vessel. The apparatus was heated at 60 0 C with shaking under psi of hydrogen for 20 hours.
i-CILII-IIX After 20 h the reaction mixture was removed from the reaction pressure vessel. The vessel was rinsed with methanol (3 mL) which was combined with the reaction mixture. The solution was concentrated under reduced pressure to an off-white solid. The crude reaction mixture gave a 97:3 ratio of the R:S hydroxy amides.
The yield was EXAMPLE 9 S1 OMs 'H 0.75% HCI, MeOH
NNHCH
3
N
Boc O O 0.25% [Et 2
NH
2 ]+[Ru 2 CIs((S)-BINAP) 2 S. 150 psi H 2 20h, 40 0
C
21 OMs MW363.40
NHCH
3
N
Boc OH
O
22 20 22 MW 265.40 o* In a 25 mL round bottom flask with a septum the 3-keto amide mesylate 21 (0.957 g) was dissolved in methanol (2.5 mL). The solution was deoxygenated with nitrogen for 20 minutes and then the finely ground [(C2H5)2NH2]+[Ru2Cl5((S)-BINAP) 2 catalyst (11 mg) (prepared as described in Example 1) was added. The solution was degassed with nitrogen for 5 minutes and 2N hydrochloric acid (0.020 mL) was added. The mixture was cannulated into the reaction pressure vessel. The apparatus was heated at 40 0 C with stirring under 150 psi of hydrogen for 20 hours.
After 20 h the reaction mixture was removed from the reaction pressure vessel. The vessel was rinsed with methanol (3 mL) which was combined with the reaction mixture. The solution was -21 concentrated under reduced pressure to an off-white solid. The crude reaction mixture gave a 91:9 ratio of the R:S hydroxy amide mesylates.
The yield was EXAMPLE (R)-Trans-2-Methoxvcarbonvlcvclopentanol 2 -Methoxycarbonyl-cyclopentanone (4.26 g) was dissolved in methanol (5 mL) and 0.1 mL IN HCI was added. The mixture was deoxygenated, 1 (36 mg) was added and the mixture was exposed to hydrogen at 40 psi and 400 in a Parr shaker apparatus. After 6 h the reaction was complete, providing a single product (4.10 g) in >95% ee: 1 H NMR (CDC13, 250 MHz) 4.40 J=7.5 Hz, 1H), 3.71 3H), 2.65 J=7.2 Hz, 1H), 2.1-1.5 6H).
EXAMPLE 11 Methyl 3 -Hvdroxv-2-methvlbutvrate Methyl 2 -methylacetoacetate was hydrogenated under the 20 conditions set forth in Example 2 or 3, to give a 6:4 mixture of trans:cis product. Enantiomeric excess of the major isomer was >97%.
EXAMPLE 12 Methyl A mixture of methyl levulinate (10.0 g, 77 mmol), methanol (10 mL) and concentrated HC1 (0.4 mL) was deoxygenated with bubbling nitrogen for 2 minutes. [(C2H5)2NH2]+[Ru2C15((R)- BINAP)2]- (50 mg) was added and the mixture placed in a standard Parr shaker apparatus. After evacuating and flushing with nitrogen three times, the mixture was evacuated and exposed to 40 psi hydrogen pressure at 40 0 C for 48 h. The solvent was removed in vacuo to give the product (9.90g, 99% yield) which was identical to a commercially available (Aldrich) racemic sample by 1H NMR. The optical purity was shown to be 99:1 by obtaining proton NMR spectrum of the product (1 -22mL) and (S)-(+)-2,2,2-trifluro-l-(9-anthryl)ethanol (27 mg) in CDC13.
Peak assignments were made by spiking with a sample of the racemate.
Methyl 5-(R)-hydroxyvalerate spontaneously lactonizes to give y-valerolactone.
EXAMPLE 13 Ethyl 3-hydroxybutvrate This was prepared from ethyl acetoacetate in ethanol 10 according to the procedure of Example 4 or 5. Enantiomeric excess was measured to be 97%. 1H NMR (CDC13, 250 MHz) 4.20 1H), 4.10 J=7.5 Hz, 1H), 2.51 2H), 1.2

Claims (3)

1. A compound of structural formula: Cl Cl or solvates thereof wherein 'P P represents BINAP or I-B INAP.
2 Acopund of structural formula: CI U Cl H 2 or solvates thereof wherein P represents BINAP or t-BINAP.
3. A compound of structural formula: E) [E2H] R C* P\ .I a.l P io or sovtsteefweenrpeet IA rtBN Dae 5 etmbr19 MECK CO,.NC MERCKSO CoERUSOC Aa07612
AU89399/98A 1994-01-05 1998-10-19 Chiral ruthenium (II) BINAP and t-BINAP compounds Ceased AU712507B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU89399/98A AU712507B2 (en) 1994-01-05 1998-10-19 Chiral ruthenium (II) BINAP and t-BINAP compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/177,481 US5508435A (en) 1992-07-29 1994-01-05 Asymmetric hydrogenation of beta- or gamma-ketoesters and beta- or gamma-ketoamides
US177481 1994-01-05
AU15226/95A AU696140B2 (en) 1994-01-05 1995-01-03 Asymetric hydrogenation of beta - or gamma-ketoesters and beta - or gamma-ketoamides
AU89399/98A AU712507B2 (en) 1994-01-05 1998-10-19 Chiral ruthenium (II) BINAP and t-BINAP compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU15226/95A Division AU696140B2 (en) 1994-01-05 1995-01-03 Asymetric hydrogenation of beta - or gamma-ketoesters and beta - or gamma-ketoamides

Publications (2)

Publication Number Publication Date
AU8939998A AU8939998A (en) 1999-01-21
AU712507B2 true AU712507B2 (en) 1999-11-11

Family

ID=25615882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89399/98A Ceased AU712507B2 (en) 1994-01-05 1998-10-19 Chiral ruthenium (II) BINAP and t-BINAP compounds

Country Status (1)

Country Link
AU (1) AU712507B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295109A1 (en) * 1987-06-11 1988-12-14 Takasago International Corporation Process for preparing optically active alcohol
AU1522695A (en) * 1994-01-05 1995-08-01 Merck & Co., Inc. Asymetric hydrogenation of beta - or gamma-ketoesters and beta - or gamma-ketoamides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295109A1 (en) * 1987-06-11 1988-12-14 Takasago International Corporation Process for preparing optically active alcohol
AU1522695A (en) * 1994-01-05 1995-08-01 Merck & Co., Inc. Asymetric hydrogenation of beta - or gamma-ketoesters and beta - or gamma-ketoamides

Also Published As

Publication number Publication date
AU8939998A (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU696140B2 (en) Asymetric hydrogenation of beta - or gamma-ketoesters and beta - or gamma-ketoamides
Yoshida et al. Cis dihydride diphosphine complexes of platium (II) and their dehydrogenation to form dimeric platinum (0) complexes. The structure of [Pt (tert-Bu) 2P (CH2) 3P (tert-Bu) 2] 2
Gridnev et al. Asymmetric Hydrogenation Catalyzed by (S, S)‐R‐BisPast;‐Rh and (R, R)‐R‐MiniPHOS Complexes: Scope, Limitations, and Mechanism
Wilson et al. Bis (2-diphenylphosphinoethyl) amine. A flexible synthesis of functionalized chelating diphosphines
AU652756B2 (en) Chiral phospholane transition metal catalysts
US6720439B1 (en) Synthesis of ruthenium-hydride complexes and preparation procedures of chiral alcohols and ketones
CN1202052C (en) Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
AU2007292167A1 (en) Process for production of optically active aminophosphinylbutanoic acid
AU712507B2 (en) Chiral ruthenium (II) BINAP and t-BINAP compounds
US20140088303A1 (en) Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol
US20040215027A1 (en) Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts
EP1483273B1 (en) Ligands for asymmetric reactions
CN1495189B (en) Preparation method of phosphite ester and transition metal complex
EP1692151B1 (en) Ferrocenyl-1, 2-diphosphines, the production thereof and their use
US5128488A (en) Process for the asymmetric hydrogenation of carbonyl compounds obtained
WO2010072746A1 (en) Chiral ligands
Chen et al. Insertion reactions of hydridonitrosyltetrakis (trimethylphosphine) tungsten (0)
Wroblewski et al. Optical resolution of the antitumor agents isophosphamide and triphosphamide by means of diastereomeric platinum (II) complexes
Zhong et al. Novel synthesis of (. eta. 3-allyl) platinum (II) complexes from enol triflates and simple olefins and their regiospecific deprotonation
ES2249152B1 (en) CATALYST FOR ENANTIOSELECTIVE HYDROGENATION REACTIONS, PREPARATION AND USE PROCEDURE.
King et al. Multinuclear NMR Observation of a Ru (ll)-BINAP Catalyst and Possible Intermediates in the Reduction of Ketoesters
US5473092A (en) Synthesis of optically-active phosphono analogs of succinates
EP3194332A1 (en) Dihydrogen production process
Dubé Organometallic transformations of di-and trivalent samarium supported by polydentate macrocyclic ligands: Low-valent samarium complexes of di-and tetrapyrrole ligand systems.
Xue et al. Synthesis of diphosphites from trans, trans‐spiro [4.4] nonane‐l, 6‐diol and their application in rh‐catalyzed asymmetric hydroformylation of styrene

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired